2 active not recruiting, 1 completed, 1 terminated, 1 withdrawn. 3 Phase 1, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 1, Completed 1, Terminated 1 |
| Not applicable | 1 | Withdrawn 1 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Stage II Cervical Cancer AJCC v7: new trials by email Literature Review of Stage II Cervical Cancer AJCC v7 trials Research Report on Stage II Cervical Cancer AJCC v7
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Triapine With Chemotherapy and Radiation Therapy in Treating Patients With IB2-IVA Cervical or Vaginal Cancer Biospecimen Collection, Brachytherapy, Cisplatin - Advanced Cervical Adenocarcinoma, Advanced Cervical Adenosquamous Carcinoma | Phase 1 | Active not recruiting | National Cancer Institute (NCI) | 21 | 2019-09-18 | 2026-07-31 |
| Testing AZD1775 inC Combination With Radiotherapy and Chemotherapy in Cervical, Upper Vaginal and Uterine Cancers Adavosertib, Cisplatin, External Beam Radiation Therapy - Cervical Carcinoma, Endometrioid Adenocarcinoma | Phase 1 | Terminated | National Cancer Institute (NCI) | 10 | 2018-05-29 | 2024-02-20 |
| Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer Internet-Based Intervention, Quality-of-Life Assessment, Questionnaire Administration - Endometrial Carcinoma, Stage 0 Fallopian Tube Cancer AJCC v7 | Not applicable | Withdrawn | Rutgers, The State University of New Jersey | 2016-07-27 | 2021-04-19 | |
| Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers Brachytherapy, Cisplatin, External Beam Radiation Therapy - Advanced Vaginal Adenocarcinoma, Advanced Vaginal Adenosquamous Carcinoma | Phase 3 | Active not recruiting | National Cancer Institute (NCI) | 450 | 2016-05-10 | 2026-10-22 |
| Chemoradiation Therapy and Ipilimumab in Treating Patients With Stages IB2-IIB or IIIB-IVA Cervical Cancer Cisplatin, External Beam Radiation Therapy, Internal Radiation Therapy - Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma | Phase 1 | Completed | National Cancer Institute (NCI) | 34 | 2012-10-01 | 2020-09-02 |
Uterine Cervical Neoplasms (5) · Vaginal Neoplasms (2) · Carcinoma, Endometrioid (1) · Endometrial Neoplasms (1) · Fallopian Tube Neoplasms (1)
Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Genital Diseases (5) · Genital Diseases, Female (5) · Genital Neoplasms, Female (5) · Neoplasms (5) · Neoplasms by Site (5) · Urogenital Diseases (5) · Urogenital Neoplasms (5) · Uterine Cervical Diseases (5) · Uterine Diseases (5) · Uterine Neoplasms (5) · Adnexal Diseases (2) · Vaginal Diseases (2) · Adenocarcinoma (1)
1,2-diaminocyclohexaneplatinum II citrate (4) · Cisplatin (4) · Platinum (4) · Radiation (4) · Brachytherapy (3) · Congresses as Topic (3) · 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (2) · Radiotherapy, Intensity-Modulated (2) · CTLA-4 Antigen (1) · Fluorodeoxyglucose F18 (1) · Ipilimumab (1) · Magnetic Resonance Spectroscopy (1) · Radiotherapy (1) · Specimen Handling (1) · adavosertib (1)
National Cancer Institute (NCI) (4) · Rutgers, The State University of New Jersey (1)
United States (5) · Canada (2) · Puerto Rico (1)
Charles A Leath (1) · Jyoti S Mayadev (1) · Sarah E Taylor (1) · Sharon Manne (1) · Stephanie Lheureux (1)
PMID 29868473, PMID 31681600, PMID 32816895, PMID 39673591
U10CA180868 (2), P30CA072720 (1), U10CA027469 (1), U10CA180830 (1), UM1CA186644 (1), UM1CA186690 (1)